Position in URGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$713,404
+$186,665 QoQ
Shares Held
19,386
-13.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 190 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $414,894,447 across 381 Biotechnology names. URGN ranks #147 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in URGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $713,404 | 19,386 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $526,739 | 22,491 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $584,574 | 29,302 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $287,195 | 25,967 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $198,526 | 18,641 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $296,938 | 23,381 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | $241,393 | 23,323 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $187,566 | 22,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $237,690 | 29,022 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||